International Clinical Trial: An open-label clinical trial assessing the safety, tolerability, and initial efficacy of oral Fecal Microbiota Transplantation capsules (from healthy donors) for adult Clostridioides difficile infection

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117356) titled 'An open-label clinical trial assessing the safety, tolerability, and initial efficacy of oral Fecal Microbiota Transplantation capsules (from healthy donors) for adult Clostridioides difficile infection' on Jan. 22.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Fujian Medical University Union Hospital

Condition: Clostridioides difficile infection

Intervention: Low-dose group:Fecal microbiota transplantation(FMT) Medium-dose group:Fecal microbiota transplantation(FMT)

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-22

Target Sample Size: Low-dos...